<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46-molecules-25-04693">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guaraldi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Meschiari</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cozzi-Lepri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Milic</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tonelli</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Menozzi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Franceschini</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Cuomo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Orlando</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Borghi</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tocilizumab in patients with severe COVID-19: A retrospective cohort study</article-title>
  <source>Lancet Rheumatol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/S2665-9913(20)30173-9</pub-id>
 </element-citation>
</ref>
